表紙
市場調查報告書
商品編碼
963242

免疫抑製藥市場 - 預測,主要企業的簡介,主要國家市場分析,COVID-19復甦方案:2020年∼2030年

Immunosuppressive Drugs Market Report 2020-2030: Forecasts by Drug Class, Applications, Route of Administration, Distribution Channel, Profiles of Leading Immunosuppressive Drugs Companies, Leading National Market Analysis, COVID-19 Recovery Scenarios

出版日期: | 出版商: Visiongain Ltd | 英文 413 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

本報告提供全球抗菌藥市場相關調查分析,主要趨勢,R&D的進展,收益預測,主要企業等相關的系統性資訊。

目錄

第1章 報告概要

第2章 免疫抑製藥市場摘要整理

第3章 免疫抑製藥市場市場概要

  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 市場機會
    • 市場課題
    • SWOT分析
    • 波特的五力分析
    • PEST分析

第4章 全球免疫抑製藥的市場規模預測:各藥物分類(COVID前,COVID復甦方案)

  • 市場概要
  • 全球免疫抑製藥市場:COVID-19復甦預測
  • 抗體
  • Calcineurin抑制劑
  • mTOR抑制劑
  • 皮質類固醇
  • 其他

第5章 全球免疫抑製藥的市場規模預測:各適應症(COVID前,COVID復甦方案)

  • 市場概要
  • 自體免疫疾病
  • 器官移植

第6章 全球免疫抑製藥市場分析與預測:各給藥途徑(COVID前,COVID復甦方案)

  • 市場概要
    • 口服藥
    • 靜脈注射藥

第7章 全球免疫抑製藥市場分析與預測:各流通管道(COVID前,COVID復甦方案)

  • 市場概要
    • 醫院藥局
    • 零售藥局
    • 線上藥局

第8章 免疫抑製藥:研發產品線分析

  • 研發產品線概要
    • Cosentyx (secukinumab)
    • RINVOQ (upadacitinib)
    • SKYRIZI (risankizumab)
    • RG7845 (GDC-0853)
    • RG7413 (etrolizumab)
    • Benlysta + Rituxan
    • STELARA (ustekinumab)
    • TREMFYA (guselkumab)
    • OTEZLA (apremilast)
    • NULOJIX (belatacept)

第9章 北美的免疫抑製藥市場分析與預測(COVID前,COVID復甦方案)

第10章 歐洲的免疫抑製藥市場分析與預測(COVID前,COVID復甦方案)

第11章 亞太地區的免疫抑製藥市場分析與預測(COVID前,COVID復甦方案)

第12章 南美的免疫抑製藥市場分析與預測(COVID前,COVID復甦方案)

第13章 中東、非洲的免疫抑製藥市場分析與預測(COVID前,COVID復甦方案)

第14章 免疫抑製藥市場企業

  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Johnson and Johnson
  • Novartis AG
  • Sanofi SA
  • Eli Lilly and Company
  • AbbVie Inc.
  • Amgen Inc.
  • Bristol Myers Squibb Company
  • Astellas Pharma Inc.
  • 其他值得注意的企業

第15章 結論

第16章 詞彙表

目錄
Product Code: PHA0493

Title:
Immunosuppressive Drugs Market Report 2020-2030
Forecasts by Drug Class (Antibodies, Calcineurin Inhibitor, mTOR Inhibitor, Corticosteroids, Others) by Applications (Autoimmune Diseases: Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Crohn's Disease, Others; Organ Transplant), by Route of Administration (Oral Drugs, Intravenous Drugs), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies). PLUS Profiles of Leading Immunosuppressive Drugs Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Immunosuppressive Drugs Market-our new study reveals trends, R&D progress, and predicted revenues

Where is the immunosuppressive drugs market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead

Our 413 page report provides 243 tables and 280 charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Immunosuppressive Drugs Market. See how to exploit the opportunities.

Forecasts to 2030 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are 4 segmentations of the Immunosuppressive Drugs Market, with forecasts for 5 Drug Classes, 5 Applications, 2 Route of Administrations Type, & 3 Distribution Channels and each forecasted at a global and regional level.

By Drug Class

  • Antibodies
  • Calcineurin Inhibitor
  • mTOR Inhibitor
  • Corticosteroids
  • Others

By Application

  • Autoimmune Diseases
    • Rheumatoid Arthritis
    • Multiple Sclerosis
    • Psoriasis
    • Crohn's Disease
    • Others
  • Organ Transplant

By Route of Administration

  • Oral Drugs
  • Intravenous Drugs

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 16 leading national markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

The report also includes profiles and for some of the leading companies in the Immunosuppressive Drugs Market, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

Overall world revenue for Immunosuppressive Drugs Market will surpass $xx million in 2020, our work calculates. We predict significant revenue growth through to 2030.

Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Immunosuppressive Drugs Market report helps you

In summary, our 413 page report provides you with the following knowledge:

  • Revenue forecasts to 2030 for Immunosuppressive Drugs Market, with forecasts for Drug Classes, Applications, Route of Administrations Type, & Distribution Channels, each forecasted at a global and regional level- discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2030 for 5 regional and 16 key national markets - See forecasts for the immunosuppressive drugs market in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Also forecasted is the market in the US, Canada, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, Mexico, Brazil, Saudi Arabia, and South Africa among other prominent economies.
  • Prospects for established firms and those seeking to enter the market- including company profiles for 10 of the major companies involved in the Immunosuppressive Drugs Market. Some of the company's profiled in this report include F. Hoffmann-La Roche AG; GlaxoSmithKline Plc.; Johnson and Johnson; Novartis AG; Eli Lilly and Company; AbbVie; Amgen Inc.; and Bristol Myers Squibb Company.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Immunosuppressive Drugs Market and leading companies. You will find data, trends and predictions.

Buy our report today Immunosuppressive Drugs Market Report 2020-2030: Forecasts by Drug Class (Antibodies, Calcineurin Inhibitor, mTOR Inhibitor, Corticosteroids, Others) by Applications (Autoimmune Diseases: Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Crohn's Disease, Others; Organ Transplant), by Route of Administration (Oral Drugs, Intravenous Drugs), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies). PLUS Profiles of Leading Immunosuppressive Drugs Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Avoid missing out by staying informed - order our report now.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Introduction
    • 1.1.1. What are Immunosuppressive Drugs?
    • 1.1.2. Side Effects of Immunosuppressive Drugs?
    • 1.1.3. What are Autoimmune Diseases?
    • 1.1.4. What is Transplantation
    • 1.1.5. What is Organ Rejection?
    • 1.1.6. Immunosuppressive Drugs for Organ Transplant
    • 1.1.7. Types of Immunosuppressive Drugs
  • 1.2. Global Immunosuppressive Drugs Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. What This Report Delivers
  • 1.5. Key Questions Answered By This Analytical Report Include:
  • 1.6. Who is This Report For?
  • 1.7. Methodology
    • 1.7.1. COVID-19 Impact: Recovery Scenarios
    • 1.7.2. Market Evaluation & Forecasting Methodology
    • 1.7.3. Market Size Estimation
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Executive Summary of the Immunosuppressive Drugs Market

3. Market Overview of the Immunosuppressive Drugs Market

  • 3.1. Market Dynamics
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing Prevalence of Autoimmune Diseases
      • 3.1.1.2. Rising Number of Organ Transplant Procedures
      • 3.1.1.3. Launch of New Immunosuppressive Drugs
    • 3.1.2. Market Restraints
      • 3.1.2.1. Adverse-Effects and Risks of Immunosuppressive Drugs
      • 3.1.2.2. High Cost of Immunosuppressant Drugs
      • 3.1.2.3. Product Recall
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Large Amount of R&D Investment by Pharmaceutical Companies
      • 3.1.3.2. Government and NGO's Initiatives for Organ Donation Awareness Programmes
      • 3.1.3.3. Presence of Reimbursement Policies for Immunosuppressive Drugs
    • 3.1.4. Market Challenges
      • 3.1.4.1. Transplant Rejection
      • 3.1.4.2. Shortage of Organ Donors
    • 3.1.5. SWOT Analysis
      • 3.1.5.1. Strengths
        • 3.1.5.1.1. Promising Candidates in R&D
        • 3.1.5.1.2. Unmet Clinical Need
      • 3.1.5.2. Weaknesses
        • 3.1.5.2.1. High Cost of Immunosuppressive Drugs
        • 3.1.5.2.2. Generic Drugs Competition
      • 3.1.5.3. Opportunities
        • 3.1.5.3.1. Increasing Mergers & Acquisitions and Collaborations
        • 3.1.5.3.2. Large Amount of R&D Investment
      • 3.1.5.4. Threats
        • 3.1.5.4.1. Ethical and Cultural Issues
    • 3.1.6. Porter's Five Forces Analysis
      • 3.1.6.1. Competitive Rivalry
      • 3.1.6.2. Supplier Power
      • 3.1.6.3. Buyer Power
      • 3.1.6.4. Threat of Substitution
      • 3.1.6.5. Threat of New Entry
    • 3.1.7. PEST Analysis
      • 3.1.7.1. Political Issues: Stringent Government Regulations
      • 3.1.7.2. Economic Pressures Raise Demand for Cost Effective Drugs
      • 3.1.7.3. Social Factors: Increase of Disposable Income
      • 3.1.7.4. Technological Factors: Adoption of High-end Technologies by Pharmaceutical and Biotechnology Companies

4. Global Immunosuppressive Drugs Market Size Forecast 2020-2030 by Drug Class (Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 4.1. Market Overview
  • 4.2. Global Immunosuppressive Drugs Market: COVID-19 Recovery Forecasts (V,U, W, L) 2020-2030
    • 4.2.1. "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
    • 4.2.2. "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
    • 4.2.3. "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
    • 4.2.4. "L" Shaped Recovery - Rapid Decline - Then Slow Growth
  • 4.3. Antibodies
    • 4.3.1. Significantly decreased the occurrence of episodes of acute rejection
  • 4.4. Calcineurin Inhibitor
    • 4.4.1. Growing adoption for the treatment of patients with organ transplant
  • 4.5. mTOR Inhibitor
    • 4.5.1. Some of the commonly used mTOR inhibitor drugs are rapamycin, sirolimus, temsirolimus, and everolimus
  • 4.6. Corticosteroids
    • 4.6.1. Effectiveness in a wide range of immune and inflammatory conditions
  • 4.7. Other Drug Classes
    • 4.7.1. Rising investment in R&D by pharmaceutical and biopharmaceutical companies boosts the segment growth

5. Global Immunosuppressive Drugs Market Size Forecast 2020-2030 by Application (Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 5.1. Market Overview
  • 5.2. Autoimmune Diseases
    • 5.2.1. Rising adoption of biologics for the treatment of autoimmune diseases
    • 5.2.2. Rheumatoid Arthritis
      • 5.2.2.1. Prevalence of rheumatoid arthritis is the high in developed countries
    • 5.2.3. Multiple Sclerosis
      • 5.2.3.1. Immunosuppressive drugs are most successful in stages of MS with an inflammatory component
    • 5.2.4. Psoriasis
      • 5.2.4.1. Patients with moderate-to-severe psoriasis are commonly treated with systemic immunosuppressants
    • 5.2.5. Crohn's Disease
      • 5.2.5.1. Some common immunosuppressive drugs used for the treatment of Crohn's disease are azathioprine (Imuran), mercaptopurine (Purinethol), cyclosporine (Gengraf, Neoral, Sandimmune), and methotrexate
    • 5.2.6. Other Autoimmune Diseases
      • 5.2.6.1. Rising incidence of other autoimmune diseases projected to boost the segment growth
  • 5.3. Organ Transplant
    • 5.3.1. A large number of transplantation procedures were reported in developed regions such as the U.S., U.K., Germany, and France

6. Global Immunosuppressive Drugs Market Analysis and Forecast, 2020-2030 by Route of Administration (Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 6.1. Market Overview
    • 6.1.1. Oral Drugs
      • 6.1.1.1. The largest revenue grossing segment in 2019
    • 6.1.2. Intravenous Drugs
      • 6.1.2.1. Mounting adoption for the treatment of patients with organ transplant

7. Global Immunosuppressive Drugs Market Analysis and Forecast, 2020-2030 by Distribution Channel (Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 7.1. Market Overview
    • 7.1.1. Hospital Pharmacies
      • 7.1.1.1. Accounted for the largest revenue share in 2019
    • 7.1.2. Retail Pharmacies
      • 7.1.2.1. One of the most preferred channel of distribution
    • 7.1.3. Online Pharmacies
      • 7.1.3.1. Provide better pricing, with increased access, convenience, and greater privacy for users.

8. Immunosuppressive Drugs: R&D Pipeline Analysis, 2020

  • 8.1. R&D Pipeline Overview
    • 8.1.1. Cosentyx (secukinumab)
      • 8.1.1.1. A fully human injectable monoclonal antibody
    • 8.1.2. RINVOQ (upadacitinib)
      • 8.1.2.1. It is an investigational oral JAK1-selective inhibitor
    • 8.1.3. SKYRIZI (risankizumab)
      • 8.1.3.1. EC granted marketing authorization for SKYRIZI for moderate to severe plaque psoriasis
    • 8.1.4. RG7845 (GDC-0853)
      • 8.1.4.1. A novel tyrosine kinase (BTK) inhibitor
    • 8.1.5. RG7413 (etrolizumab)
      • 8.1.5.1. Clinical trials are underway to test etrolizumab in ulcerative colitis and Crohn's disease
    • 8.1.6. Benlysta + Rituxan
      • 8.1.6.1. Clinical study to investigates Benlysta in combination with rituximab in adult patients with SLE
    • 8.1.7. STELARA (ustekinumab)
      • 8.1.7.1. Showed positive outcomes as maintenance therapy in adults patients with moderate to severe ulcerative colitis
    • 8.1.8. TREMFYA (guselkumab)
      • 8.1.8.1. New clinical study data from two Phase III trials
    • 8.1.9. OTEZLA (apremilast)
      • 8.1.9.1. Positive results from the Phase III trial
    • 8.1.10. NULOJIX (belatacept)
      • 8.1.10.1. Can help patients with kidney transplants safely and effectively without the long-term negative side effects

9. North America Immunosuppressive Drugs Market Analysis and Forecast, 2020-2030 Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 9.1. Market Overview
  • 9.2. North America Immunosuppressive Drugs Market Size and Forecast by Country
    • 9.2.1. The Largest Revenue Grossing Region
  • 9.3. North America Immunosuppressive Drugs Market Size and Forecast by Drug Class
    • 9.3.1. Antibodies Sub-Segment Will Dominate The Market
  • 9.4. North America Immunosuppressive Drugs Market Size and Forecast by Application
    • 9.4.1. Organ Transplant Segment Will Witness Fastest Growth Rate
  • 9.5. North America Immunosuppressive Drugs Market Size and Forecast by Route of Administration
    • 9.5.1. Increasing Number of Approvals For Oral Drugs
  • 9.6. North America Immunosuppressive Drugs Market Size and Forecast by Distribution Channel
    • 9.6.1. Online Pharmacies Segment is Anticipated to Witness Highest CAGR
  • 9.7. U.S. Immunosuppressive Drugs Market
    • 9.7.1. Presence of Leading Vendors
    • 9.7.2. Rise in the Number of Drug Approvals
  • 9.8. Canada Immunosuppressive Drugs Market
    • 9.8.1. High Investment in Drug R&D
    • 9.8.2. Growing Number of Organ Transplant Procedures

10. Europe Immunosuppressive Drugs Market Analysis and Forecast, 2020-2030 (Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 10.1. Market Overview
  • 10.2. Europe Immunosuppressive Drugs Market Size and Forecast by Country
    • 10.2.1. The Second Largest Regional Market
  • 10.3. Europe Immunosuppressive Drugs Market Size and Forecast by Drug Class
    • 10.3.1. Calcineurin Inhibitor Segment Expected to Grow at Lucrative Rate
  • 10.4. Europe Immunosuppressive Drugs Market Size and Forecast by Application
    • 10.4.1. Easy Access to Advanced Immunosuppressive Drugs for the Treatment of Autoimmune Diseases
  • 10.5. Europe Immunosuppressive Drugs Market Size and Forecast by Route of Administration
    • 10.5.1. High Adoption of Oral Drugs
  • 10.6. Europe Immunosuppressive Drugs Market Size and Forecast by Distribution Channel
    • 10.6.1. Growing Preference for Online Pharmacies
  • 10.7. UK Immunosuppressive Drugs Market
    • 10.7.1. A Hub for Advanced Drugs Development and Production
    • 10.7.2. Increasing Prevalence of Autoimmune Diseases
  • 10.8. Germany Immunosuppressive Drugs Market
    • 10.8.1. Strong Funding for Healthcare
    • 10.8.2. Universal Health Systems
  • 10.9. France Immunosuppressive Drugs Market
    • 10.9.1. Increasing Number of Organ Transplant Procedures
    • 10.9.2. High Quality Renowned Medical Care With Innovation
  • 10.10. Italy Immunosuppressive Drugs Market
    • 10.10.1. Disinvestment, Delocalization, and Restructuring of Italian Pharmaceutical Companies
    • 10.10.2. A Large Pharmaceutical Manufacturing Hub
  • 10.11. Spain Immunosuppressive Drugs Market
    • 10.11.1. Presence of Innovation Infrastructure and Government Funding
    • 10.11.2. Availability of Highly Skilled Workforce
  • 10.12. Russia Immunosuppressive Drugs Market
    • 10.12.1. An Attractive Market for Any Industry Looking to Expand Within the Country
    • 10.12.2. Government Support for Development of the Healthcare Sector
  • 10.13. Rest of Europe Immunosuppressive Drugs Market
    • 10.13.1. The EU Action Plan on the Organ Donation and Transplantation
    • 10.13.2. Rising Incidences of Autoimmune Diseases

11. Asia Pacific Immunosuppressive Drugs Market Analysis and Forecast, 2020-2030 (Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 11.1. Market Overview
  • 11.2. Asia Pacific Immunosuppressive Drugs Market Size and Forecast by Country
    • 11.2.1. Asia Pacific market expected to grow at fastest rate
  • 11.3. Asia Pacific Immunosuppressive Drugs Market Size and Forecast by Drug Class
    • 11.3.1. mTOR Inhibitor segment projected to grow at significant CAGR during 2020-2030
  • 11.4. Asia Pacific Immunosuppressive Drugs Market Size and Forecast by Application
    • 11.4.1. Rising incidence of organ failure and autoimmune diseases in Asia Pacific
  • 11.5. Asia Pacific Immunosuppressive Drugs Market Size and Forecast by Route of Administration
    • 11.5.1. Rising adoption of injectable drugs
  • 11.6. Asia Pacific Immunosuppressive Drugs Market Size and Forecast by Distribution Channel
    • 11.6.1. Rapidly developing economies, skilled workers, and technological innovation
  • 11.7. Japan Immunosuppressive Drugs Market
    • 11.7.1. Presence of Leading Pharmaceutical Companies
    • 11.7.2. High Investment in R&D
  • 11.8. China Immunosuppressive Drugs Market
    • 11.8.1. Government Support to Strengthen the Healthcare Infrastructure
    • 11.8.2. Presence of Large Geriatric Population
  • 11.9. India Immunosuppressive Drugs Market
    • 11.9.1. Availability of Large Trained Workforce
    • 11.9.2. Growing Technical Capabilities
  • 11.10. Australia Immunosuppressive Drugs Market
    • 11.10.1. Australia Has a Rich Research Environment Coupled with Highly Experienced Researchers and Professionals
    • 11.10.2. Excellent Health Care Infrastructure
  • 11.11. Rest of Asia Pacific Immunosuppressive Drugs Market
    • 11.11.1. Increasing Incidence of Autoimmune and Inflammatory Diseases
    • 11.11.2. Rising Disposable Income

12. Latin America Immunosuppressive Drugs Market Analysis and Forecast, 2020-2030 (Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 12.1. Market Overview
  • 12.2. Latin America Immunosuppressive Drugs Market Size and Forecast by Country
    • 12.2.1. Developing healthcare infrastructure
  • 12.3. Latin America Immunosuppressive Drugs Market Size and Forecast by Drug Class
    • 12.3.1. Antibodies was the largest revenue grossing subsegment
  • 12.4. Latin America Immunosuppressive Drugs Market Size and Forecast by Application
    • 12.4.1. Organ transplant segment will witness fastest growth rate
  • 12.5. Latin America Immunosuppressive Drugs Market Size and Forecast by Route of Administration
    • 12.5.1. Oral Drugs segment projected to dominate the market during the forecast period 2020-2030
  • 12.6. Latin America Immunosuppressive Drugs Market Size and Forecast by Distribution Channel
    • 12.6.1. Retail pharmacies segment accounted for significant revenue share
  • 12.7. Brazil Immunosuppressive Drugs Market
    • 12.7.1.1. Growing Disposable Income
    • 12.7.1.2. Rapidly Improving Healthcare Infrastructure
  • 12.8. Mexico Immunosuppressive Drugs Market
    • 12.8.1.1. Affordable Treatments Option for Organ Transplant
    • 12.8.1.2. Government Initiatives That Aim at Providing Better Healthcare Facilities
  • 12.9. Rest of Latin America Immunosuppressive Drugs Market
    • 12.9.1.1. Growing Burden of Autoimmune Diseases
    • 12.9.1.2. Availability of Skilled and Inexpensive Workforce

13. MEA Immunosuppressive Drugs Market Analysis and Forecast, 2020-2030 (Pre COVID and V, U, W and L COVID Recovery Scenarios)

  • 13.1. Market Overview
  • 13.2. MEA Immunosuppressive Drugs Market Size and Forecast by Country
    • 13.2.1. Developing Healthcare Infrastructure
  • 13.3. MEA Immunosuppressive Drugs Market Size and Forecast by Drug Class
    • 13.3.1. Corticosteroids Segment Expected to Show Lucrative Growth Rate
  • 13.4. MEA Immunosuppressive Drugs Market Size and Forecast by Application
    • 13.4.1. Organ Transplant Segment Will Witness Fastest Growth Rate
  • 13.5. MEA Immunosuppressive Drugs Market Size and Forecast by Route of Administration
    • 13.5.1. Rising Adoption of Oral Drugs For the Treatment of Patients With Organ Transplant
  • 13.6. MEA Immunosuppressive Drugs Market Size and Forecast by Distribution Channel
    • 13.6.1. Hospital Pharmacies Dominated the Market
  • 13.7. Saudi Arabia Immunosuppressive Drugs Market
    • 13.7.1.1. Presence of huge growth opportunities
    • 13.7.1.2. Introduction of the Medical Aid Schemes Bill, National Health Insurance Bill, and introduction of new regulator for medicines
  • 13.8. South Africa Immunosuppressive Drugs Market
    • 13.8.1.1. Rising focus of pharmaceutical & biotechnology companies in this region
    • 13.8.1.2. An emerging economy
  • 13.9. Rest of MEA Immunosuppressive Drugs Market
    • 13.9.1.1. Developing Healthcare Infrastructure
    • 13.9.1.2. Rising Prevalence of Chronic Autoimmune Diseases

14. Companies in the Immunosuppressive Drugs Market

  • 14.1. F. Hoffmann-La Roche AG
    • 14.1.1. Company Snapshot
    • 14.1.2. Company Overview
    • 14.1.3. Financial Performance (2015-2020)
      • 14.1.3.1. Net Revenue ($mn), 2015-2019
      • 14.1.3.2. Segment Revenue Share, 2019
      • 14.1.3.3. Geographical Revenue, 2019
    • 14.1.4. Product Offerings
    • 14.1.5. Recent Initiatives (2017-2020)
  • 14.2. GlaxoSmithKline Plc
    • 14.2.1. Company Snapshot
    • 14.2.2. Company Overview
    • 14.2.3. Financial Performance (2015-2019)
      • 14.2.3.1. Net Revenue
      • 14.2.3.2. Segment Revenue Share, 2019
      • 14.2.3.3. Geographical Revenue, 2019
    • 14.2.4. Product Offerings
    • 14.2.5. Recent Initiatives (2017-2020)
  • 14.3. Johnson and Johnson
    • 14.3.1. Company Snapshot
    • 14.3.2. Company Overview
    • 14.3.3. Financial Performance (2015-2019)
      • 14.3.3.1. Net Revenue
      • 14.3.3.2. Segment Revenue Share, 2019
      • 14.3.3.3. Geographical Revenue, 2019
    • 14.3.4. Product Offerings
    • 14.3.5. Recent Initiatives (2017-2020)
  • 14.4. Novartis AG
    • 14.4.1. Company Snapshot
    • 14.4.2. Company Overview
    • 14.4.3. Financial Performance (2015-2019)
      • 14.4.3.1. Net Revenue
      • 14.4.3.2. Segment Revenue Share, 2019
      • 14.4.3.3. Geographical Revenue, 2019
    • 14.4.4. Product Offerings
    • 14.4.5. Recent Initiatives (2017-2020)
  • 14.5. Sanofi SA
    • 14.5.1. Company Snapshot
    • 14.5.2. Company Overview
    • 14.5.3. Financial Performance (2015-2019)
      • 14.5.3.1. Net Revenue
      • 14.5.3.2. Segment Revenue Share, 2019
      • 14.5.3.3. Geographical Revenue, 2019
    • 14.5.4. Product Offerings
    • 14.5.5. Recent Initiatives (2017-2020)
  • 14.6. Eli Lilly and Company
    • 14.6.1. Company Snapshot
    • 14.6.2. Company Overview
    • 14.6.3. Financial Performance (2015-2019)
      • 14.6.3.1. Net Revenue
      • 14.6.3.2. Segment Revenue Share, 2019
      • 14.6.3.3. Geographical Revenue, 2019
    • 14.6.4. Product Offerings
    • 14.6.5. Recent Initiatives (2017-2020)
  • 14.7. AbbVie Inc.
    • 14.7.1. Company Snapshot
    • 14.7.2. Company Overview
    • 14.7.3. Financial Performance (2015-2019)
      • 14.7.3.1. Net Revenue
      • 14.7.3.2. Segment Revenue Share, 2019
      • 14.7.3.3. Geographical Revenue, 2019
    • 14.7.4. Product Offerings
    • 14.7.5. Recent Initiatives (2017-2020)
  • 14.8. Amgen Inc.
    • 14.8.1. Company Snapshot
    • 14.8.2. Company Overview
    • 14.8.3. Financial Performance (2015-2019)
      • 14.8.3.1. Net Revenue
      • 14.8.3.2. Segment Revenue Share, 2019
      • 14.8.3.3. Geographical Revenue, 2019
    • 14.8.4. Product Offerings
    • 14.8.5. Recent Initiatives (2017-2020)
  • 14.9. Bristol Myers Squibb Company
    • 14.9.1. Company Snapshot
    • 14.9.2. Company Overview
    • 14.9.3. Financial Performance (2015-2019)
      • 14.9.3.1. Net Revenue
      • 14.9.3.2. Segment Revenue Share, 2019
      • 14.9.3.3. Geographical Revenue, 2019
    • 14.9.4. Product Offerings
    • 14.9.5. Recent Initiatives (2017-2020)
  • 14.10. Astellas Pharma Inc.
    • 14.10.1. Company Snapshot
    • 14.10.2. Company Overview
    • 14.10.3. Financial Performance (2015-2019)
      • 14.10.3.1. Net Revenue
      • 14.10.3.2. Segment Revenue Share, 2019
      • 14.10.3.3. Geographical Revenue, 2019
    • 14.10.4. Product Offerings
  • 14.11. Other Notable Players

15. Conclusion

16. Glossary

List of Tables

  • Table 1 Global Immunosuppressive Drugs Market, 2020-2030 (US$ billion, CAGR %)
  • Table 2 Prevalence of Autoimmune Diseases, 2020
  • Table 3 Prevalence of Autoimmune Diseases, 2020
  • Table 4 Immunosuppressant Drugs: Average Cost per Set Period of Time by Dose
  • Table 5 Total R&D Investment by Leading Players
  • Table 6 Major M&A and Collaborations: Immunosuppressive Drugs Market
  • Table 7 Global Immunosuppressive Drugs Market Forecast by Drug Class, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 8 "V" Shaped Recovery: Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 9 "U" Shaped Recovery: Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 10 "W" Shaped Recovery: Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 11 "L" Shaped Recovery: Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 12 Global Immunosuppressive Drugs Market for Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 13 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 14 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 15 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 16 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 17 Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 18 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 19 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 20 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 21 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 22 Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 23 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 24 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 25 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 26 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 27 Global Immunosuppressive Drugs Market for Corticosteroids Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 28 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 29 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 30 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 31 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 32 Global Immunosuppressive Drugs Market for Other Drug Classes Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 33 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Other Drug Classes Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 34 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Other Drug Classes Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 35 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Other Drug Classes Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 36 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Other Drug Classes Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 37 Global Immunosuppressive Drugs Market Forecast by Application, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 38 Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 39 Global Autoimmune Diseases Market Forecast by Type, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 40 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 41 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 42 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 43 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 44 Global Autoimmune Diseases Market for Rheumatoid Arthritis Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 45 Global Autoimmune Diseases Market for Multiple Sclerosis Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 46 Global Autoimmune Diseases Market for Psoriasis Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 47 Global Autoimmune Diseases Market for Crohn's Disease Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 48 Global Autoimmune Diseases Market for Other Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 49 Global Immunosuppressive Drugs Market for Organ Transplant Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 50 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Organ Transplant Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 51 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Organ Transplant Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 52 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Organ Transplant Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 53 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Organ Transplant Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 54 Global Immunosuppressive Drugs Market Forecast by Route of Administration, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 55 Global Immunosuppressive Drugs Market for Oral Drugs Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 56 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Oral Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 57 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Oral Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 58 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Oral Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 59 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Oral Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 60 Global Immunosuppressive Drugs Market for Intravenous Drugs Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 61 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Intravenous Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 62 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Intravenous Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 63 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Intravenous Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 64 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Intravenous Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 65 Global Immunosuppressive Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 66 Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 67 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 68 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 69 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 70 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 71 Global Immunosuppressive Drugs Market for Retail Pharmacies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 72 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 73 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 74 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 75 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 76 Global Immunosuppressive Drugs Market for Online Pharmacies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 77 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Online Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 78 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Online Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 79 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Online Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 80 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Online Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 81 Leading Gene Therapy Drugs by Revenue ($bn), 2019
  • Table 82 Global Immunosuppressive Drugs Market Forecast by Region, 2020-2030 (US$ billion, AGR %)
  • Table 83 "V" Shaped Recovery: Global Immunosuppressive Drugs Market Forecast by Region, 2020-2030 (US$ billion, AGR %)
  • Table 84 "U" Shaped Recovery: Global Immunosuppressive Drugs Market Forecast by Region, 2020-2030 (US$ billion, AGR %)
  • Table 85 "W" Shaped Recovery: Global Immunosuppressive Drugs Market Forecast by Region, 2020-2030 (US$ billion, AGR %)
  • Table 86 "L" Shaped Recovery: Global Immunosuppressive Drugs Market Forecast by Region, 2020-2030 (US$ billion, AGR %)
  • Table 87 North America Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 88 North America Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 89 North America Immunosuppressive Drugs Market Forecast by Drug Class, 2020-2030 (US$ billion, AGR %)
  • Table 90 North America Immunosuppressive Drugs Market Forecast by Application, 2020-2030 (US$ billion, AGR %)
  • Table 91 North America Autoimmune Diseases Market Forecast by Type, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 92 North America Immunosuppressive Drugs Market Forecast by Route of Administration, 2020-2030 (US$ billion, AGR %)
  • Table 93 North America Immunosuppressive Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR %)
  • Table 94 U.S. Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 95 "V" Shaped Recovery: U.S. Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 96 "U" Shaped Recovery: U.S. Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 97 "W" Shaped Recovery: U.S. Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 98 "L" Shaped Recovery: U.S. Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 99 Canada Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 100 "V" Shaped Recovery: Canada Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 101 "U" Shaped Recovery: Canada Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 102 "W" Shaped Recovery: Canada Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 103 "L" Shaped Recovery: Canada Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 104 Organ Transplant Procedures in Europe, 2017 & 2018
  • Table 105 Europe Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 106 Europe Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 107 Europe Immunosuppressive Drugs Market Forecast by Drug Class, 2020-2030 (US$ billion, AGR %)
  • Table 108 Europe Immunosuppressive Drugs Market Forecast by Application, 2020-2030 (US$ billion, AGR %)
  • Table 109 Europe Autoimmune Diseases Market Forecast by Type, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 110 Europe Immunosuppressive Drugs Market Forecast by Route of Administration, 2020-2030 (US$ billion, AGR %)
  • Table 111 Europe Immunosuppressive Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR %)
  • Table 112 Germany Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 113 "V" Shaped Recovery: Germany Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 114 "U" Shaped Recovery: Germany Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 115 "W" Shaped Recovery: Germany Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 116 "L" Shaped Recovery: Germany Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 117 UK Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 118 "V" Shaped Recovery: UK Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 119 "U" Shaped Recovery: UK Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 120 "W" Shaped Recovery: UK Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 121 "L" Shaped Recovery: UK Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 122 France Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 123 "V" Shaped Recovery: France Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 124 "U" Shaped Recovery: France Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 125 "W" Shaped Recovery: France Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 126 "L" Shaped Recovery: France Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 127 Italy Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 128 "V" Shaped Recovery: Italy Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 129 "U" Shaped Recovery: Italy Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 130 "W" Shaped Recovery: Italy Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 131 "L" Shaped Recovery: Italy Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 132 Spain Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 133 "V" Shaped Recovery: Spain Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 134 "U" Shaped Recovery: Spain Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 135 "W" Shaped Recovery: Spain Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 136 "L" Shaped Recovery: Spain Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 137 Russia Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 138 "V" Shaped Recovery: Russia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 139 "U" Shaped Recovery: Russia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 140 "W" Shaped Recovery: Russia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 141 "L" Shaped Recovery: Russia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 142 Rest of Europe Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 143 "V" Shaped Recovery: Rest of Europe Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 144 "U" Shaped Recovery: Rest of Europe Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 145 "W" Shaped Recovery: Rest of Europe Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 146 "L" Shaped Recovery: Rest of Europe Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 147 No. of Organ Transplant Procedures in Asia Pacific, 2018
  • Table 148 Asia Pacific Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 149 Asia Pacific Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 150 Asia Pacific Immunosuppressive Drugs Market Forecast by Drug Class, 2020-2030 (US$ billion, AGR %)
  • Table 151 Asia Pacific Immunosuppressive Drugs Market Forecast by Application, 2020-2030 (US$ billion, AGR %)
  • Table 152 Asia Pacific Autoimmune Diseases Market Forecast by Type, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 153 Asia Pacific Immunosuppressive Drugs Market Forecast by Route of Administration, 2020-2030 (US$ billion, AGR %)
  • Table 154 Asia Pacific Immunosuppressive Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR %)
  • Table 155 Japan Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 156 "V" Shaped Recovery: Japan Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 157 "U" Shaped Recovery: Japan Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 158 "W" Shaped Recovery: Japan Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 159 "L" Shaped Recovery: Japan Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 160 China Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 161 "V" Shaped Recovery: China Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 162 "U" Shaped Recovery: China Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 163 "W" Shaped Recovery: China Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 164 "L" Shaped Recovery: China Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 165 India Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 166 "V" Shaped Recovery: India Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 167 "U" Shaped Recovery: India Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 168 "W" Shaped Recovery: India Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 169 "L" Shaped Recovery: India Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 170 Australia Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 171 "V" Shaped Recovery: Australia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 172 "U" Shaped Recovery: Australia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 173 "W" Shaped Recovery: Australia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 174 "L" Shaped Recovery: Australia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 175 Rest of Asia Pacific Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 176 "V" Shaped Recovery: Rest of Asia Pacific Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR %)
  • Table 177 "U" Shaped Recovery: Rest of Asia Pacific Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 178 "W" Shaped Recovery: Rest of Asia Pacific Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 179 "L" Shaped Recovery: Rest of Asia Pacific Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 180 Latin America Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 181 Latin America Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 182 Latin America Immunosuppressive Drugs Market Forecast by Drug Class, 2020-2030 (US$ billion, AGR %)
  • Table 183 Latin America Immunosuppressive Drugs Market Forecast by Application, 2020-2030 (US$ billion, AGR %)
  • Table 184 Latin America Autoimmune Diseases Market Forecast by Type, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 185 Latin America Immunosuppressive Drugs Market Forecast by Route of Administration, 2020-2030 (US$ billion, AGR %)
  • Table 186 Latin America Immunosuppressive Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR %)
  • Table 187 Brazil Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 188 "V" Shaped Recovery: Brazil Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 189 "U" Shaped Recovery: Brazil Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 190 "W" Shaped Recovery: Brazil Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 191 "L" Shaped Recovery: Brazil Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 192 Mexico Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 193 "V" Shaped Recovery: Mexico Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 194 "U" Shaped Recovery: Mexico Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 195 "W" Shaped Recovery: Mexico Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 196 "L" Shaped Recovery: Mexico Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 197 Rest of Latin America Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 198 "V" Shaped Recovery: Rest of Latin America Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 199 "U" Shaped Recovery: Rest of Latin America Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 200 "W" Shaped Recovery: Rest of Latin America Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 201 "L" Shaped Recovery: Rest of Latin America Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 202 MEA Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 203 MEA Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 204 MEA Immunosuppressive Drugs Market Forecast by Drug Class, 2020-2030 (US$ billion, AGR %)
  • Table 205 MEA Immunosuppressive Drugs Market Forecast by Application, 2020-2030 (US$ billion, AGR %)
  • Table 206 MEA Autoimmune Diseases Market Forecast by Type, 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 207 MEA Immunosuppressive Drugs Market Forecast by Route of Administration, 2020-2030 (US$ billion, AGR %)
  • Table 208 MEA Immunosuppressive Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ billion, AGR %)
  • Table 209 South Africa Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 210 "V" Shaped Recovery: South Africa Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 211 "U" Shaped Recovery: South Africa Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 212 "W" Shaped Recovery: South Africa Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 213 "L" Shaped Recovery: South Africa Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 214 Saudi Arabia Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 215 "V" Shaped Recovery: Saudi Arabia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 216 "U" Shaped Recovery: Saudi Arabia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 217 "W" Shaped Recovery: Saudi Arabia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 218 "L" Shaped Recovery: Saudi Arabia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 219 Rest of MEA Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %, CAGR %)
  • Table 220 "V" Shaped Recovery: Rest of MEA Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 221 "U" Shaped Recovery: Rest of MEA Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 222 "W" Shaped Recovery: Rest of MEA Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 223 "L" Shaped Recovery: Rest of MEA Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%, CAGR%)
  • Table 224 F. Hoffmann-La Roche AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 225 F. Hoffmann-La Roche AG: Major Products
  • Table 226 GlaxoSmithKline Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 227 GlaxoSmithKline PLC: Major Products
  • Table 228 Johnson & Johnson Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 229 Johnson and Johnson: Major Products
  • Table 230 Novartis AG Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 231 Novartis AG: Major Products
  • Table 232 Sanofi SA Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 233 Sanofi SA: Major Products
  • Table 234 Eli Lilly and Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 235 Eli Lilly and Company: Major Products
  • Table 236 AbbVie Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 237 AbbVie: Major Products
  • Table 238 Amgen Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 239 Amgen Inc.: Major Products
  • Table 240 Bristol Myers Squibb Company Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 241 Bristol Myers Squibb Company: Major Products
  • Table 242 Astellas Pharma Inc. Profile 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 243 Astellas Pharma Inc.: Major Products

List of Figures

  • Figure 1 Global Immunosuppressive Drugs Market Segmentation
  • Figure 2 Global Immunosuppressive Drugs Market Overview,2020
  • Figure 3 Porter's Five Forces Analysis,2020
  • Figure 4 SWOT Analysis,2020
  • Figure 5 PEST Analysis, 2020
  • Figure 6 Global Immunosuppressive Drugs Market Forecast by Drug Class, 2020-2030 (US$ billion)
  • Figure 7 Global Immunosuppressive Drugs Market Share Forecast by Drug Class, 2020, 2025, 2030 (%)
  • Figure 8 "V" Shaped Recovery: Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 9 "U" Shaped Recovery: Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 10 "W" Shaped Recovery: Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 11 "L" Shaped Recovery: Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 12 Global Immunosuppressive Drugs Market for Antibodies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 13 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 14 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 15 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 16 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Antibodies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 17 .Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 18 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 19 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 20 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 21 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Calcineurin Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 22 Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 23 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 24 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 25 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 26 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for mTOR Inhibitor Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 27 Global Immunosuppressive Drugs Market for Corticosteroids Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 28 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 29 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 30 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 31 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Corticosteroids Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 32 Global Immunosuppressive Drugs Market for Other Drug Classes Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 33 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Other Drug Classes Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 34 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Other Drug Classes Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 35 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Other Drug Classes Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 36 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Other Drug Classes Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 37 Global Immunosuppressive Drugs Market Forecast by Application, 2020-2030 (US$ billion)
  • Figure 38 Global Immunosuppressive Drugs Market Share Forecast by Application, 2020, 2025, 2030 (%)
  • Figure 39 Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 40 Global Autoimmune Diseases Market Forecast by Type, 2020-2030 (US$ billion)
  • Figure 41 Global Autoimmune Diseases Market Share Forecast by Type, 2020, 2025, 2030 (%)
  • Figure 42 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 43 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 44 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 45 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Autoimmune Diseases Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 46 Global Autoimmune Diseases Market for Rheumatoid Arthritis Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 47 Global Autoimmune Diseases Market for Multiple Sclerosis Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 48 Global Autoimmune Diseases Market for Psoriasis Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 49 Global Autoimmune Diseases Market for Crohn's Disease Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 50 Global Autoimmune Diseases Market for Other Autoimmune Diseases Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 51 Global Immunosuppressive Drugs Market for Organ Transplant Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 52 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Organ Transplant Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 53 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Organ Transplant Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 54 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Organ Transplant Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 55 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Organ Transplant Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 56 Global Immunosuppressive Drugs Market Forecast by Route of Administration, 2020-2030 (US$ billion)
  • Figure 57 Global Immunosuppressive Drugs Market Share Forecast by Route of Administration, 2020, 2025, 2030 (%)
  • Figure 58 Global Immunosuppressive Drugs Market for Oral Drugs Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 59 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Oral Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 60 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Oral Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 61 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Oral Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 62 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Oral Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 63 Global Immunosuppressive Drugs Market for Intravenous Drugs Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 64 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Intravenous Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 65 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Intravenous Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 66 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Intravenous Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 67 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Intravenous Drugs Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 68 Global Immunosuppressive Drugs Market Forecast by Distribution Channel, 2020-2030 (US$ billion)
  • Figure 69 Global Immunosuppressive Drugs Market Share Forecast by Distribution Channel, 2020, 2025, 2030 (%)
  • Figure 70 Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 71 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 72 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 73 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 74 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Hospital Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 75 Global Immunosuppressive Drugs Market for Retail Pharmacies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 76 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 77 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 78 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 79 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Retail Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 80 Global Immunosuppressive Drugs Market for Online Pharmacies Segment: Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 81 "V" Shaped Recovery: Global Immunosuppressive Drugs Market for Online Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 82 "U" Shaped Recovery: Global Immunosuppressive Drugs Market for Online Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 83 "W" Shaped Recovery: Global Immunosuppressive Drugs Market for Online Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 84 "L" Shaped Recovery: Global Immunosuppressive Drugs Market for Online Pharmacies Segment, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 85 Global Immunosuppressive Drugs Market Forecast by Region 2020-2030 (US$ billion)
  • Figure 86 Global Immunosuppressive Drugs Market Share Forecast by Region 2020, 2025, 2030 (%)
  • Figure 87 North America Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 88 North America Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion)
  • Figure 89 North America Immunosuppressive Drugs Market Share Forecast by Country, 2020-2030 (%)
  • Figure 90 "V" Shaped Recovery: North America Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 91 "U" Shaped Recovery: North America Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 92 "W" Shaped Recovery: North America Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 93 "L" Shaped Recovery: North America Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 94 North America Immunosuppressive Drugs Market Share (%) Forecast by Drug Class, 2020-2030
  • Figure 95 North America Immunosuppressive Drugs Market Share (%) Forecast by Application, 2020-2030
  • Figure 96 North America Autoimmune Diseases Market Share (%) Forecast by Type, 2020-2030
  • Figure 97 North America Immunosuppressive Drugs Market Share (%) Forecast by Route of Administration, 2020-2030
  • Figure 98 North America Immunosuppressive Drugs Market Share (%) Forecast by Distribution Channel, 2020-2030
  • Figure 99 U.S. Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 100 "V" Shaped Recovery: U.S. Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 101 "U" Shaped Recovery: U.S. Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 102 "W" Shaped Recovery: U.S. Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 103 "L" Shaped Recovery: U.S. Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 104 Canada Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 105 "V" Shaped Recovery: Canada Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 106 "U" Shaped Recovery: Canada Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 107 "W" Shaped Recovery: Canada Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 108 "L" Shaped Recovery: Canada Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 109 Europe Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 110 Europe Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion)
  • Figure 111 Europe Immunosuppressive Drugs Market Share Forecast by Country 2020-2030 (%)
  • Figure 112 "V" Shaped Recovery: Europe Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 113 "U" Shaped Recovery: Europe Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 114 "W" Shaped Recovery: Europe Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 115 "L" Shaped Recovery: Europe Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 116 Europe Immunosuppressive Drugs Market Share (%) Forecast by Drug Class, 2020-2030
  • Figure 117 Europe Immunosuppressive Drugs Market Share (%) Forecast by Application, 2020-2030
  • Figure 118 Europe Autoimmune Diseases Market Share (%) Forecast by Type, 2020-2030
  • Figure 119 Europe Immunosuppressive Drugs Market Share (%) Forecast by Route of Administration, 2020-2030
  • Figure 120 Europe Immunosuppressive Drugs Market Share (%) Forecast by Distribution Channel, 2020-2030
  • Figure 121 Germany Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 122 "V" Shaped Recovery: Germany Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 123 "U" Shaped Recovery: Germany Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 124 "W" Shaped Recovery: Germany Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 125 "L" Shaped Recovery: Germany Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 126 UK Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 127 "V" Shaped Recovery: UK Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 128 "U" Shaped Recovery: UK Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 129 "W" Shaped Recovery: UK Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 130 "L" Shaped Recovery: UK Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 131 France Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 132 "V" Shaped Recovery: France Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 133 "U" Shaped Recovery: France Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 134 "W" Shaped Recovery: France Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 135 "L" Shaped Recovery: France Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 136 Italy Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 137 "V" Shaped Recovery: Italy Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 138 "U" Shaped Recovery: Italy Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 139 "W" Shaped Recovery: Italy Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 140 "L" Shaped Recovery: Italy Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 141 Spain Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 142 "V" Shaped Recovery: Spain Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 143 "U" Shaped Recovery: Spain Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 144 "W" Shaped Recovery: Spain Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 145 "L" Shaped Recovery: Spain Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 146 Russia Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 147 "V" Shaped Recovery: Russia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 148 "U" Shaped Recovery: Russia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 149 "W" Shaped Recovery: Russia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 150 "L" Shaped Recovery: Russia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 151 Rest of Europe Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 152 "V" Shaped Recovery: Rest of Europe Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 153 "U" Shaped Recovery: Rest of Europe Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 154 "W" Shaped Recovery: Rest of Europe Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 155 "L" Shaped Recovery: Rest of Europe Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 156 Asia Pacific Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 157 Asia Pacific Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion)
  • Figure 158 Asia Pacific Immunosuppressive Drugs Market Share Forecast by Country 2020, 2025, 2030 (%)
  • Figure 159 "V" Shaped Recovery: Asia Pacific Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 160 "U" Shaped Recovery: Asia Pacific Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 161 "W" Shaped Recovery: Asia Pacific Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 162 "L" Shaped Recovery: Asia Pacific Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 163 Asia Pacific Immunosuppressive Drugs Market Share (%) Forecast by Drug Class, 2020-2030
  • Figure 164 Asia Pacific Immunosuppressive Drugs Market Share (%) Forecast by Application, 2020-2030
  • Figure 165 Asia Pacific Autoimmune Diseases Market Share (%) Forecast by Type, 2020-2030
  • Figure 166 Asia Pacific Immunosuppressive Drugs Market Share (%) Forecast by Route of Administration, 2020-2030
  • Figure 167 Asia Pacific Immunosuppressive Drugs Market Share (%) Forecast by Distribution Channel, 2020-2030
  • Figure 168 Japan Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 169 "V" Shaped Recovery: Japan Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 170 "U" Shaped Recovery: Japan Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 171 "W" Shaped Recovery: Japan Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 172 "L" Shaped Recovery: Japan Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 173 China Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 174 "V" Shaped Recovery: China Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 175 "U" Shaped Recovery: China Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 176 "W" Shaped Recovery: China Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 177 "L" Shaped Recovery: China Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 178 India Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 179 "V" Shaped Recovery: India Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 180 "U" Shaped Recovery: India Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 181 "W" Shaped Recovery: India Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 182 "L" Shaped Recovery: India Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 183 Australia Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 184 "V" Shaped Recovery: Australia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 185 "U" Shaped Recovery: Australia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 186 "W" Shaped Recovery: Australia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 187 "L" Shaped Recovery: Australia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 188 Rest of Asia Pacific Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 189 "V" Shaped Recovery: Rest of Asia Pacific Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 190 "U" Shaped Recovery: Rest of Asia Pacific Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 191 "W" Shaped Recovery: Rest of Asia Pacific Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 192 "L" Shaped Recovery: Rest of Asia Pacific Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 193 Latin America Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 194 Latin America Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion)
  • Figure 195 Latin America Immunosuppressive Drugs Market Share Forecast by Country 2020-2030 (%)
  • Figure 196 "V" Shaped Recovery: Latin America Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 197 "U" Shaped Recovery: Latin America Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 198 "W" Shaped Recovery: Latin America Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 199 "L" Shaped Recovery: Latin America Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 200 Latin America Immunosuppressive Drugs Market Share (%) Forecast by Drug Class, 2020-2030
  • Figure 201 Latin America Immunosuppressive Drugs Market Share (%) Forecast by Application, 2020-2030
  • Figure 202 Latin America Autoimmune Diseases Market Share (%) Forecast by Type, 2020-2030
  • Figure 203 Latin America Immunosuppressive Drugs Market Share (%) Forecast by Route of Administration, 2020-2030
  • Figure 204 Latin America Immunosuppressive Drugs Market Share (%) Forecast by Distribution Channel, 2020-2030
  • Figure 205 Brazil Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 206 "V" Shaped Recovery: Brazil Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 207 "U" Shaped Recovery: Brazil Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 208 "W" Shaped Recovery: Brazil Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 209 "L" Shaped Recovery: Brazil Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 210 Mexico Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 211 "V" Shaped Recovery: Mexico Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 212 "U" Shaped Recovery: Mexico Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 213 "W" Shaped Recovery: Mexico Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 214 "L" Shaped Recovery: Mexico Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 215 Rest of Latin America Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 216 "V" Shaped Recovery: Rest of Latin America Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 217 "U" Shaped Recovery: Rest of Latin America Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 218 "W" Shaped Recovery: Rest of Latin America Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 219 "L" Shaped Recovery: Rest of Latin America Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 220 MEA Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 221 MEA Immunosuppressive Drugs Market Forecast by Country, 2020-2030 (US$ billion)
  • Figure 222 MEA Immunosuppressive Drugs Market Share Forecast by Country 2020-2030 (%)
  • Figure 223 "V" Shaped Recovery: MEA Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 224 "U" Shaped Recovery: MEA Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 225 "W" Shaped Recovery: MEA Immunosuppressive Drugs Market Forecast, 2020-2030 (US$ billion, AGR%)
  • Figure 226 "L" Shaped Recovery: MEA Immunosuppressive Drugs Market Forecast , 2020-2030 (US$ billion, AGR%)
  • Figure 227 MEA Immunosuppressive Drugs Market Share (%) Forecast by Drug Class, 2020-2030
  • Figure 228 MEA Immunosuppressive Drugs Market Share (%) Forecast by Application, 2020-2030
  • Figure 229 MEA Autoimmune Diseases Market Share (%) Forecast by Type, 2020-2030
  • Figure 230 MEA Immunosuppressive Drugs Market Share (%) Forecast by Route of Administration, 2020-2030
  • Figure 231 MEA Immunosuppressive Drugs Market Share (%) Forecast by Distribution Channel, 2020-2030
  • Figure 232 South Africa Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 233 "V" Shaped Recovery: South Africa Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 234 "U" Shaped Recovery: South Africa Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 235 "W" Shaped Recovery: South Africa Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 236 "L" Shaped Recovery: South Africa Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 237 Saudi Arabia Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 238 "V" Shaped Recovery: Saudi Arabia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 239 "U" Shaped Recovery: Saudi Arabia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 240 "W" Shaped Recovery: Saudi Arabia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 241 "L" Shaped Recovery: Saudi Arabia Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 242 Rest of MEA Immunosuppressive Drugs Market Forecast 2020-2030 (US$ billion, AGR %)
  • Figure 243 "V" Shaped Recovery: Rest of MEA Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 244 "U" Shaped Recovery: Rest of MEA Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 245 "W" Shaped Recovery: Rest of MEA Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 246 "L" Shaped Recovery: Rest of MEA Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 247 Immunosuppressive Drugs Market: Company Share Analysis (%), 2019
  • Figure 248 F. Hoffmann-La Roche AG: Revenue ($mn), 2015-2019
  • Figure 249 F. Hoffmann-La Roche AG: Segment Revenue Share (%), 2019
  • Figure 250 F. Hoffmann-La Roche AG: Pharmaceutical Segment Revenue Share (%), 2019
  • Figure 251 GlaxoSmithKline PLC: Revenue ($mn), 2015-2019
  • Figure 252 GlaxoSmithKline PLC: Segment Revenue Share (%), 2019
  • Figure 253 GlaxoSmithKline PLC: Pharmaceuticals Segment Revenue Share (%), 2019
  • Figure 254 GlaxoSmithKline PLC: Regional Revenue Share (%), 2019
  • Figure 255 Johnson & Johnson: Revenue ($mn), 2015-2019
  • Figure 256 Johnson & Johnson: Segment Revenue Share (%), 2019
  • Figure 257 Johnson & Johnson: Regional Revenue Share (%), 2019
  • Figure 258 Novartis AG: Revenue ($mn), 2015-2019
  • Figure 259 Novartis AG: Segment Revenue Share (%), 2019
  • Figure 260 Novartis AG: Regional Revenue Share (%), 2019
  • Figure 261 Sanofi SA: Revenue ($mn), 2015-2019
  • Figure 262 Sanofi SA: Segment Revenue Share (%), 2019
  • Figure 263 Sanofi SA: Regional Revenue Share (%), 2019
  • Figure 264 Eli Lilly and Company: Revenue ($mn), 2015-2019
  • Figure 265 Eli Lilly and Company: Segment Revenue Share (%), 2019
  • Figure 266 Eli Lilly and Company: Region Revenue Share (%), 2019
  • Figure 267 AbbVie: Revenue ($mn), 2015-2019
  • Figure 268 AbbVie: Segment Revenue Share (%), 2019
  • Figure 269 AbbVie: Segment Revenue Share (%), 2019
  • Figure 270 Amgen Inc.: Revenue ($mn), 2015-2019
  • Figure 271 Amgen Inc.: Segment Revenue Share (%), 2019
  • Figure 272 Amgen Inc.: Region Revenue Share (%), 2019
  • Figure 273 Bristol Myers Squibb: Revenue ($mn), 2015-2019
  • Figure 274 Bristol Myers Squibb: Segment Revenue Share (%), 2019
  • Figure 275 Bristol Myers Squibb: Region Revenue Share (%), 2019
  • Figure 276 Astellas Pharma Inc.: Revenue ($mn), 2015-2019
  • Figure 277 Astellas Pharma Inc.: Segment Revenue Share (%), 2019
  • Figure 278 Astellas Pharma Inc.: Region Revenue Share (%), 2019
  • Figure 279 Global Immunosuppressive Drugs Market, Revenue Forecast 2020-2030 (US$ billion, AGR%)
  • Figure 280 Global Immunosuppressive Drugs Market Forecast by Region 2020-2030 (US$ billion)

Companies Profiled in the Report:

  • AbbVie Inc
  • Amgen Inc
  • Astellas Pharma Inc
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Novartis AG
  • Sanofi SA

List of Companies Mentioned in the Report:

  • Ablynx
  • Alembic Pharmaceuticals Ltd
  • Allergan plc
  • Alniche Life Sciences Pvt Ltd
  • Asahi Kasei Pharma
  • Aurolab
  • Biocon Ltd.
  • Calren Care Lifesciences Pvt Ltd
  • Celgene Corporation
  • Centaur Pharmaceuticals Pvt Ltd
  • Cipla
  • Csc Pharmaceuticals
  • Dermira, Inc.,
  • Dr Johns Lab Pharma Pvt Ltd
  • Dr Reddys Laboratories Ltd
  • East West Pharma
  • Elder Projects Ltd
  • Elinor Pharmaceuticals Pvt Ltd
  • Entod Pharmaceuticals Ltd
  • Galcare Pharmaceuticals Pvt Ltd
  • Goddres Pharmaceuticals Pvt Ltd
  • Incyte Corporation
  • Indiabulls Pharmaceutical Ltd
  • Intas Pharmaceuticals Ltd
  • Ipca Laboratories Ltd
  • Johnlee Pharmaceuticals Pvt Ltd
  • Koye Pharmaceuticals Pvt Ltd
  • La Pristine Bioceuticals Pvt Ltd
  • La Renon Healthcare Pvt Ltd
  • Lead Pharma
  • Leeford Healthcare Ltd
  • Lgm Pharma
  • Lupin Ltd
  • Macleods Pharmaceuticals Ltd
  • Mylan Pharmaceuticals Inc.
  • Ordain Healthcare
  • Par Pharmaceutical, Inc
  • Rpg Life Sciences
  • Saffron Therapeutics Pvt Ltd
  • Steadfast Medishield Pvt Ltd
  • Sumac Pharma Pvt Ltd
  • Sun Pharmaceutical Industries Ltd
  • Swiss Pharma Pvt. Ltd.
  • Synergy Pharmaceuticals
  • Synthorx, Inc.
  • TARIS Biomedical LLC
  • Veloxis Pharmaceuticals
  • Wallace Pharmaceuticals Pvt Ltd
  • Zuventus Healthcare Ltd
  • Zydus Healthcare Ltd

List of Organizations Mentioned in the Report:

  • Australian Bureau of Statistics (ABS)
  • Canadian Organ Replacement Register (CORR)
  • Centers for Disease Control and Prevention (CDC)
  • Centers for Medicare & Medicaid Services (CMS)
  • Department for Promotion of Industry and Internal Trade (DPIIT), India
  • European Commission (EC)
  • Global Burden of Disease Study
  • Global Observatory on Donation and Transplantation
  • Institute for Healthcare Improvement (IHI)
  • Italian Industry Group Farmindustria states
  • Japanese Ministry of Health, Labour and Welfare
  • National Center for Biotechnology Information (NCBI)
  • National Health Service (NHS)
  • National Medical Products Administration
  • National Psoriasis Foundation
  • NHS Blood and Transplant, England
  • Organization for Economic Cooperation and Development (OECD)
  • Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Public Health England
  • U.S. Department of Health and Human Services
  • US FDA